Hill Lab Ovarian Cancer Organoid and Tissue Bank:

As the Hill lab continues to generate and profile ovarian cancer organoid cultures from new patients coming to BWH/DFCI to understand disease mechanisms and to try to determine if organoid functional assays on each patient's culture will be useful in predicting patient response, we continue to generate a large bank of tissue and organoid cultures across all epithelial ovarian cancer subtypes and also generate organoids from benign fallopian tube, ovarian surface epithelium, and other matched normal cells.

​Please contact Dr. Hill to collaborate, sarah_hill@dfci.harvard.edu. We are excited to partner with other researchers for biologic discovery, therapeutic discovery, new functional assay development, and biomarker development using our organoid cultures and pathology expertise.